0886 516 705 office@healthpr.bg
  • Български
  • English
Health PR
  • Home
  • ABOUT US
    • Health PR principles
    • Competence
    • Areas of expertise
    • Partners
    • Team
    • SERVICES
    • PRIVACY POLICY
      • GENERAL TERMS AND CONDITIONS OF THE WEBSITE OF HEALTH PR
      • HEALTH PR COOKIES POLICY
      • PRIVACY POLICY
  • NEWS
  • CONTACTS
Select Page
‘Patients are not a company’s resource’: FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer

‘Patients are not a company’s resource’: FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer

by admin | Apr 19, 2019 | news

If there’s one law in oncology R&D, it’s that you don’t cross FDA cancer czar Richard Pazdur. Pazdur is famous for cutting companies to shreds during panel reviews if they come to the agency with questionable data after straying from the path he set for...
2020: What does the future hold for the manufacturing and clinical landscape?

2020: What does the future hold for the manufacturing and clinical landscape?

by Viara Staneva | Apr 10, 2019 | news

Pharma IQ spoke to Jeremy Schafer and Scott Marshall to find out their predictions. The manufacturing and clinical landscapes are set to see further change over the coming years. Pharma IQ spoke to Jeremy Schafer and Scott Marshall to find out their predictions....
‘Patients are not a company’s resource’: FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer

A key step for the future of personalized medicine: CRISPR immunity and Mathematical Cryptanalysis.

by admin | Apr 7, 2019 | news

In this analysis, Michael A. Popov, Director Researcher at Prime States Quantum Lab looks at the future trends and applications of the CRISPR Cas9 tool It could be difficult to explain simply why in the last 5 years mathematical cryptography community and community of...
Pharma’s summer of punk: Who’s playing the hits — or taking a hit — on the world innovation tour

Pharma’s summer of punk: Who’s playing the hits — or taking a hit — on the world innovation tour

by Viara Staneva | Apr 5, 2019 | news

You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals and $1,000/year for companies of every size): https://endpts.com/subscribe Already a paid subscriber? Sign in to Endpoints...
Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’

Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’

by admin | Apr 2, 2019 | news

New Orleans — New results of a gigantic study testing how well the Apple Watch detects important heart-rhythm changes offer a tantalizing glimpse of how consumer devices might change medicine and lead to new ways to conduct science — but little more. Unfortunately,...
A new regulation in force may block the patient’s access to new medicines

A new regulation in force may block the patient’s access to new medicines

by admin | Mar 20, 2019 | news

Comedian and former late night host Jay Leno isn’t laughing about his cholesterol numbers. But he is using humor to get the message across in an awareness campaign with Amgen that focuses on the dangers of high cholesterol. The new campaign, “Cholesterol...
« Older Entries
Next Entries »

FAST LINKS

  • ABOUT US
  • SERVICES
  • EVENTS
  • NEWS
  • CONTACTS

LATEST POSTS

  • More Than Half of Doctors Now Part of Healthcare Systems 10/08/2021
  • CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage 19/04/2021
  • More anti-epidemic measures eased today 19/04/2021

CONTACTS

agsdi-location

Sofia 1000, 15 Prof. Fritiof Nansen Blvd,
ent. B, floor 1

agsdi-gmail

office@healthpr.bg



0886 516 705

All rights reserved 2018 © HealthPR | design: syreia+

We use cookies! The data collected by cookies provides you with a better experience on our website. A detailed description is given in the Privacy Policy and the Cookie Policy.OKNoLearn more